Literature DB >> 6791975

A patient with pyruvate carboxylase deficiency in the liver: treatment with aspartic acid and thiamine.

M G Baal, F J Gabreëls, W O Renier, F A Hommes, T H Gijsbers, K J Lamers, J C Kok.   

Abstract

A seven-year-old girl with slowly progressive motor neurological impairment and high levels of lactate and pyruvate in blood and cerebrospinal fluid was found to have severe hepatic pyruvate carboxylase deficiency. However, in contrast to other patients with this deficiency, no mental retardation was apparent. Treatment with aspartic acid and thiamine over a period of seven years resulted in biochemical improvement and a stable neurological condition. The level of cognitive functioning remained the same. When treatment with aspartic acid was temporarily discontinued, lactate and pyruvate concentrations increased so markedly that the drug was resumed. This indicates that aspartic acid was the effective drug, and that the effect of thiamine was secondary.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791975     DOI: 10.1111/j.1469-8749.1981.tb02026.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Pyruvate carboxylase defect: metabolic studies on cultured skin fibroblasts.

Authors:  J Oizumi; W G Ng; G N Donnell
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 2.  Therapy of mitochondrial disorders.

Authors:  H Przyrembel
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Pyruvate carboxylase deficiency.

Authors:  K Bartlett; H K Ghneim; J H Stirk; G Dale; K G Alberti
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

4.  Organic acids in urine of patients with congenital lactic acidoses: an aid to differential diagnosis.

Authors:  R A Chalmers
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.